| | | LONDON (Reuters) - BP has put its U.S. wind farm operation, one of the largest in the country, up for sale, marking the continued retreat of big oil companies from renewable energy investments while oil and gas projects offer them better returns. | | | | | | LONDON (Reuters) - AstraZeneca boosted its early-stage pipeline of experimental heart drugs on Wednesday by buying privately held U.S. biotechnology company AlphaCore Pharma, which is developing a new type of cholesterol medicine. | | | | | | | LONDON (Reuters) - Glencore said on Tuesday it had again extended the date by which it expects to close its merger with Xstrata, due to the ongoing investigation into the deal in China. | | | | | DUBLIN (Reuters) - Investment firm Royalty Pharma must either announce an offer for Irish drugmaker Elan by May 10 or not proceed with a $6.6 billion approach, Ireland's Takeover Panel said on Wednesday. | | | | | | | LONDON (Reuters) - Shares in Vodafone fell on Wednesday after Verizon Communications ruled out a full takeover, turning the focus yet again to whether the two telecom giants can do a deal over their Verizon Wireless joint venture. | | | | | | | PARIS (Reuters) - French nuclear reactor maker Areva said it had agreed to sell its nuclear radiation measurement unit, Canberra, to private equity group Astorg Partners for an undisclosed amount. | | | | | | | NEW YORK/LONDON (Reuters) - At least three of the world's top drugmakers are bidding for Brazil's Ache Laboratorios Farmaceuticos in an auction that may value the group at more than $5 billion, people familiar with the matter said. | | | | | | | STOCKHOLM (Reuters) - Tele2 said it stood to gain more than the $3.5 billion price agreed for its Russian unit if the buyer sells it again within a year, as the Swedish telecoms group tries to fend off competing bids from industry rivals. | | | | NEW YORK (Reuters) - Thermo Fisher Scientific Inc is emerging as the lead contender in an auction for Life Technologies Corp , a genetic testing maker with a market value of more than $11 billion, three people familiar with the matter said this week. | | | | | | ZURICH (Reuters) - Julius Baer has transferred ownership of businesses in Chile, Uruguay, Monaco and Luxembourg which it bought from Merrill Lynch as it integrates the wealth management businesses it acquired from the U.S. bank. | | | | | | | A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today | | | | | | | The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today | | | | | » MORE NEWSLETTERS | |
No comments:
Post a Comment